ArticleRisk management and healthcare policy2024

Evaluation of Inflammatory Markers in Patients with COVID-19 Combined with Type 2 Diabetes Mellitus.

Jingjing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.